376 related articles for article (PubMed ID: 30738960)
1. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
Feng LL; Shen FR; Zhou JH; Chen YG
Gene; 2019 May; 696():105-112. PubMed ID: 30738960
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
Wang W; Xing C
Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828
[TBL] [Abstract][Full Text] [Related]
3. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
4. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
5. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
[TBL] [Abstract][Full Text] [Related]
6. Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
Bo H; Fan L; Gong Z; Liu Z; Shi L; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li G; Xiong W; Zeng Z; Cao K; Zhang S; Xiong F
Oncol Rep; 2019 Apr; 41(4):2431-2439. PubMed ID: 30816545
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.
Wang JS; Liu QH; Cheng XH; Zhang WY; Jin YC
Biomed Pharmacother; 2018 Jul; 103():174-181. PubMed ID: 29653362
[TBL] [Abstract][Full Text] [Related]
8. ZFAS1 knockdown inhibits viability and enhances cisplatin cytotoxicity by up-regulating miR-432-5p in glioma cells.
Yang G; Han B; Feng T
Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):518-526. PubMed ID: 31246330
[TBL] [Abstract][Full Text] [Related]
9. Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21.
Yao T; Lu R; Zhang J; Fang X; Fan L; Huang C; Lin R; Lin Z
J Cell Physiol; 2019 Jun; 234(6):9605-9615. PubMed ID: 30352127
[TBL] [Abstract][Full Text] [Related]
10. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS
PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880
[TBL] [Abstract][Full Text] [Related]
11. LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.
Xu QF; Tang YX; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4440-4447. PubMed ID: 30058681
[TBL] [Abstract][Full Text] [Related]
12. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
Zhou ZP; Wang LP; Hong ZS; Qiu CZ; Wang MZ; Chen ZX; Tang LF; Yu WS; Wang CX
Int J Oncol; 2018 Sep; 53(3):1183-1192. PubMed ID: 30015866
[TBL] [Abstract][Full Text] [Related]
13. MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1.
Chen J; Li G
Biomed Pharmacother; 2018 Nov; 107():997-1003. PubMed ID: 30257412
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MEG3 has anti-activity effects of cervical cancer.
Wang X; Wang Z; Wang J; Wang Y; Liu L; Xu X
Biomed Pharmacother; 2017 Oct; 94():636-643. PubMed ID: 28787698
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
Sun XH; Fan WJ; An ZJ; Sun Y
Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X
Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA HOTAIR and STAT3 synergistically regulate the cervical cancer cell migration and invasion.
Zhang Y; Cheng X; Liang H; Jin Z
Chem Biol Interact; 2018 Apr; 286():106-110. PubMed ID: 29572071
[TBL] [Abstract][Full Text] [Related]
18. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
19. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ.
Yang W; Yang X; Wang X; Gu J; Zhou D; Wang Y; Yin B; Guo J; Zhou M
J Cell Mol Med; 2019 Aug; 23(8):4921-4932. PubMed ID: 31245927
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]